The Claim
In adults with moderate to severe depression receiving cognitive-behavioral therapy, supplementation with 5 grams per day of creatine monohydrate for 8 weeks has no statistically significant effect on the rate of all-cause treatment discontinuation compared to placebo.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with moderate to severe depression who are undergoing cognitive-behavioral therapy, taking 5 grams of creatine monohydrate daily for 8 weeks does not change the rate at which people stop their treatment compared to taking a placebo.
See the scientific wording
In adults with moderate to severe depression, creatine monohydrate supplementation (5g/day) for 8 weeks does not significantly alter the rate of all-cause treatment discontinuation compared to placebo when combined with cognitive-behavioral therapy.
Creatine supplementation does not change how the brain or body responds to therapy, so people continue or stop treatment at the same rate whether they take creatine or not.
What the research says
1 studyPeople taking creatine with therapy quit treatment at the same rate as those taking a placebo, so creatine doesn’t make people drop out more often.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.